Peripheral Blood Flow Responses to Electromagnetic Energy

Exposure to Man-made Visible Light Clinical Trial

Official title: Peripheral Blood Flow Responses to Electromagnetic Energy

Status Recruiting

Clinical Trial Summary

This study evaluates 670 nm energy in the form of red light to stimulate blood flow changes in healthy adults. All participants will receive red light to their leg. They will also receive a continuous infusion of Definity (octafluoropropane) ultrasound contrast.

Clinical Trial Description

670 nm energy in the form of red light dilates isolated blood vessels. This study seeks to measure vessel dilation in human subjects exposed to this energy at different irradiance intensities (25 milliwatts (mW)/cm2 and 75 mW/cm2). The intent of this protocol is to measure blood flow in the gastrocnemius muscle before and after exposure to 670 nm light energy. This protocol will be performed in healthy subjects, who do not meet exclusion criteria. The study consists of one visit. Blood flow measurement will be performed using contrast enhanced ultrasound, a method by which ultrasound contrast is continuously infused into the blood stream. Ultrasound records images in the area of interest and flow is related to the intensity of the contrast in each image. After baseline blood flow images are collected, the subject will receive red light energy to the gastrocnemius muscle with concurrent blood flow measurements with contrast ultrasound. The subject will be monitored post procedure and the study will then be completed. ;

Related Conditions & MeSH terms

• Exposure to Man-made Visible Light

• NCT number: NCT02370199
• Study type: Interventional
• Source: University of Alabama at Birmingham
• Contact: Nicole L Lohr, MD, PhD
• Phone: 205-996-3504
• Email: nlohr@uabmc.edu
• Status: Recruiting
• Phase: N/A
• Start date: November 2014
• Completion date: May 1, 2025